Nutrition Interventions for Children with Special Health Care Needs

Chapter 5 - Medication-Nutrient Interactions
References
1. Brizee L. Medication-Nutrient Interactions Revisited. Nutrition Focus.
2006;21(5).
2. Maka D, Murphy L. Drug-nutrient interactions: A review. AACN Advanced
Critical Care. 2000;11:580-589.
3. Nicolaidou P, Georgouli H, Kotsalis H, Matsinos Y, Papadopoulou A,
Fretzayas A, Syriopoulou V, Krikos X, Karantana A, Karpathios T. Effects
of anticonvulsant therapy on vitamin D status in children: Prospective
monitoring study. J Child Neurol.2006;21:205-210.
4. Kinjo M, Setoguchi S, Schneeweiss S, Solomon D. Bone mineral density
in subjects using central nervous system-active medications. Am J of
Medicine.2005;118:1414.e7-1414e12.
5. Holick MF. Medical progress: Vitamin D deficiency. N Eng J Med.
2007;357:266-281.
6. Bikle DD. What is new in vitamin D: 2006-2007.Curr Opin Rheumatol.,
2007;19:383-388.
7. Drezner M. Treatment of anticonvulsant drug-induced bone disease. Epilepsy
& Behavior.2004;5:S41-47.
8. Huemer M, Ausserer B, Graninger G, Hubmann M, Huemer C, Schlachter K,
Tscharre A, Ulmer H, Simma. B. Hyperhomocysteinemia in children treated
with antiepileptic drugs is normalized by folic acid supplementation. Epilepsia.
2005;46:1677-1683.
9. Hamed S, Nabeshima T. The high atherosclerotic risk among epileptics: the
atheroprotective role of multivitamins. J Pharmacol Sci. 2005;98:340-353.
10. Coppola G, Epifanio G, Auricchio G, Federico R, Resicato G, Pascotto A.
Plasma free carnitine in epilepsy children, adolescents and young adults
treated with old and new antiepileptic drugs with or without ketogenic diet.
Brain & Development. 2006;28:358-365.
11. Moreno F, Macey H, Schreiber B. Carnitine levels in valproic acid-treated
psychiatric patients: a cross-sectional study. J Clin Psychiatry. 2005;66:555-
558.
68 Nutrition Interventions for Children With Special Health Care Needs